168 related articles for article (PubMed ID: 24323923)
1. One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?
Soto AM; Sonnenschein C
Bioessays; 2014 Jan; 36(1):118-20. PubMed ID: 24323923
[No Abstract] [Full Text] [Related]
2. Normal Somatic Mutations in Cancer Transformation.
Wijewardhane N; Dressler L; Ciccarelli FD
Cancer Cell; 2021 Feb; 39(2):125-129. PubMed ID: 33220180
[TBL] [Abstract][Full Text] [Related]
3. Re: a cancer theory kerfuffle can lead to new lines of research.
Kaye FJ
J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766401
[No Abstract] [Full Text] [Related]
4. Response.
Baker SG
J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766402
[No Abstract] [Full Text] [Related]
5. SMT and TOFT Integrable After All: A Reply to Bizzarri and Cucina.
Bedessem B; Ruphy S
Acta Biotheor; 2017 Mar; 65(1):81-85. PubMed ID: 27535677
[TBL] [Abstract][Full Text] [Related]
6. A cancer theory kerfuffle can lead to new lines of research.
Baker SG
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25528755
[TBL] [Abstract][Full Text] [Related]
7. Cancer, stem cell misplacement and cancer stem cells.
Liao Y
J Cell Mol Med; 2013 Sep; 17(9):1194-5. PubMed ID: 23855541
[TBL] [Abstract][Full Text] [Related]
8. The stem cell division theory of cancer.
López-Lázaro M
Crit Rev Oncol Hematol; 2018 Mar; 123():95-113. PubMed ID: 29482784
[TBL] [Abstract][Full Text] [Related]
9. Biological techniques: An embryonic view of tumour development.
Schweiger PJ; Jensen KB
Nature; 2013 Sep; 501(7466):171-2. PubMed ID: 23945591
[No Abstract] [Full Text] [Related]
10. Mouse models: Novel in vivo RNAi screen in mice.
Lokody I
Nat Rev Cancer; 2013 Oct; 13(10):682. PubMed ID: 24030505
[No Abstract] [Full Text] [Related]
11. SMT and TOFT: Why and How They are Opposite and Incompatible Paradigms.
Bizzarri M; Cucina A
Acta Biotheor; 2016 Sep; 64(3):221-39. PubMed ID: 27283400
[TBL] [Abstract][Full Text] [Related]
12. Is cancer a breakdown of multicellularity?
Pennisi E
Science; 2018 Jun; 360(6396):1391. PubMed ID: 29954963
[No Abstract] [Full Text] [Related]
13. Over a century of cancer research: Inconvenient truths and promising leads.
Sonnenschein C; Soto AM
PLoS Biol; 2020 Apr; 18(4):e3000670. PubMed ID: 32236102
[TBL] [Abstract][Full Text] [Related]
14. Somatic Mutation Theory - Why it's Wrong for Most Cancers.
Brücher BL; Jamall IS
Cell Physiol Biochem; 2016; 38(5):1663-80. PubMed ID: 27160408
[TBL] [Abstract][Full Text] [Related]
15. Field Carcinogenesis in Cancer Evolution: What the Cell Is Going On?
Sinjab A; Han G; Wang L; Kadara H
Cancer Res; 2020 Nov; 80(22):4888-4891. PubMed ID: 33023945
[TBL] [Abstract][Full Text] [Related]
16. SigsPack, a package for cancer mutational signatures.
Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
[TBL] [Abstract][Full Text] [Related]
17. [Two Approaches to Cancer Development].
Šmardová J; Koptíková J
Klin Onkol; 2016; 29(4):259-66. PubMed ID: 27534782
[TBL] [Abstract][Full Text] [Related]
18. Preface.
Pruitt K
Prog Mol Biol Transl Sci; 2016; 144():xiii. PubMed ID: 27865470
[No Abstract] [Full Text] [Related]
19. Searching for cancer vulnerabilities amid genetic chaos.
Speicher MR
Genome Biol; 2017 Aug; 18(1):147. PubMed ID: 28768521
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated mutations in healthy individuals: assessing the risk of carcinogenesis.
Rodriguez-Brenes IA; Komarova NL; Wodarz D
Cancer Res; 2014 Mar; 74(6):1661-9. PubMed ID: 24453004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
